CymitQuimica logo
MAPK

MAPK

Le MAPK sono una famiglia di chinasi proteiche coinvolte in una varietà di processi cellulari, tra cui crescita, proliferazione, differenziazione e risposte allo stress. La via di segnalazione MAPK è composta da diversi livelli, tra cui ERK, JNK e p38 MAPK, ciascuno con ruoli distinti nella funzione cellulare. La disregolazione della segnalazione MAPK è collegata al cancro, alle malattie infiammatorie e ai disturbi metabolici. Presso CymitQuimica, offriamo una vasta gamma di inibitori e attivatori delle MAPK per supportare la tua ricerca in biologia cellulare, trasduzione del segnale e meccanismi delle malattie.

Trovati 892 prodotti di "MAPK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • Famlasertib

    CAS:
    Famlasertib is a potent inhibitor of the mitogen-activated protein kinase kinase kinase kinase (MAP4K) family, capable of penetrating the brain. It exhibits an IC50 value of 0.3 nM for HGK (MAP4K4) and 23.7 nM for MLK3.
    Formula:C26H27ClN4O
    Colore e forma:Solid
    Peso molecolare:446.972
  • KRAS G12C inhibitor 20

    CAS:
    KRAS G12C inhibitor 20 is a KRAS G12C inhibitor.
    Formula:C33H37ClFN7O3
    Colore e forma:Solid
    Peso molecolare:634.14
  • ATX inhibitor 26

    CAS:
    ATX inhibitor 26 is an Autotaxin (ATX) inhibitor with an IC50 of 57 nM in human plasma. It effectively inhibits cell migration and collagen gel contraction. Additionally, ATX inhibitor 26 demonstrates significant antifibrotic activity, reducing collagen deposition in a Bleomycin (BLM)-induced pulmonary fibrosis model.
    Formula:C18H19Cl2N7O3
    Colore e forma:Solid
    Peso molecolare:452.30
  • KRas G12C inhibitor 2

    CAS:
    KRas G12C inhibitor 2 is a compound that inhibits KRas G12C.
    Formula:C32H37N7O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:567.68
  • KRAS G12C inhibitor 56

    CAS:
    KRAS G12C inhibitor 56, a powerful inhibitor of SOS1 with an inhibitory concentration (IC50) of 1.6 nM, holds promise for use in cancer research.
    Formula:C32H39N7O4S
    Colore e forma:Solid
    Peso molecolare:617.76
  • p38 MAPK-IN-6

    CAS:
    <p>p38 MAPK-IN-6 (compound c47) is an inhibitor of p38 MAPK, exhibiting a 14% inhibition rate at a concentration of 10 μM.</p>
    Formula:C16H14BrN3OS2
    Colore e forma:Solid
    Peso molecolare:408.336
  • p38α MAPK/CK1δ inhibitor-1

    CAS:
    <p>p38αMAPK/CK1δ inhibitor-1 (Compound 3) exhibits inhibitory activity against p38αMAPK and CK1δ, with IC50 values of 0.185 µM and 0.089 µM, respectively.</p>
    Formula:C24H17FN6O2
    Colore e forma:Solid
    Peso molecolare:440.429
  • KRASG12D-IN-3-d3

    CAS:
    KRASG12D-IN-3-d3 is the deuterium labeled KRASG12D-IN-3. KRASG12D-IN-3 (compound Z1084) is a KRASG12D inhibitor with oral bioactivity that can effectively inhibit the growth of tumor cells AGS and AsPC-1, with IC50 values of 0.38 nM and 1.23 nM, respectively.
    Formula:C31H27D3ClF6N7O2
    Colore e forma:Soild
    Peso molecolare:685.08
  • HPK1-IN-30

    CAS:
    HPK1-IN-30 is a potent inhibitor of HPK1. HPK1-IN-30 has potential for cancer disease research.
    Formula:C25H23FN6
    Colore e forma:Solid
    Peso molecolare:426.49
  • Fulzerasib

    CAS:
    <p>Fulzerasib is an orally active KRAS G12C inhibitor that covalently binds to cysteine residue on the protein, thereby inhibiting the growth of KRAS G12C mutant</p>
    Formula:C32H30ClFN6O4
    Purezza:98.04%
    Colore e forma:Solid
    Peso molecolare:617.07
  • pan-KRAS-IN-6

    CAS:
    <p>Pan-KRAS-IN-6 (compound 12) is a potent pan-KRAS inhibitor, with IC50 values of 9.79 nM for Kras G12D and 6.03 nM for Kras G12V.</p>
    Formula:C29H30ClF3N6O3S
    Colore e forma:Solid
    Peso molecolare:635.10
  • COTI-219

    CAS:
    COTI-219 is an oral inhibitor of KRAS with antitumor properties [1].
    Formula:C17H18N6S
    Colore e forma:Solid
    Peso molecolare:338.43
  • HPK1-IN-3


    HPK1-IN-3: Selective HPK1 inhibitor, ATP-competitive, IC50=0.25nM; boosts IL-2 in PBMCs, EC50=108nM.
    Formula:C23H22F4N6O2
    Colore e forma:Solid
    Peso molecolare:490.45
  • (rel)-AR234960

    CAS:
    (rel)-AR234960 is an active relative configuration of AR234960. AR234960 is a non-peptide agonist of MAS.
    Formula:C27H30FN5O5S
    Colore e forma:Solid
    Peso molecolare:555.63
  • KRAS G12C inhibitor 37

    CAS:
    KRAS G12C inhibitor 37 targets a key signaling protein, showing promise for cancer research involving KRAS G12C.
    Formula:C35H39F3N8O2
    Colore e forma:Solid
    Peso molecolare:660.73
  • PF-03715455

    CAS:
    PF-03715455 is a potent p38 MAPK inhibitor, reducing TNFα in blood (IC50=1.7 nM) with selectivity for p38α, and may treat COPD.
    Formula:C35H34ClN7O3S2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:700.27
  • BBO-8520

    CAS:
    BBO-8520 is a dual KRASG12C inhibitor that blocks ON and OFF states, disables effector binding, suppresses signaling, and induces tumor regression.
    Formula:C35H33F6N7O2S
    Purezza:97.879%
    Colore e forma:Solid
    Peso molecolare:729.74
  • PS-166276

    CAS:
    PS-166276 is a potent p38 inhibitor with low cytotoxicity. It exhibits an IC50 value of 28 nM against p38 kinase and an IC50 of 170 nM in the THP-1 TNFα assay.
    Formula:C20H30N8O
    Colore e forma:Solid
    Peso molecolare:398.51
  • Luvometinib

    CAS:
    Luvometinib is an inhibitor of the mitogen-activated protein kinase (MEK) with antitumor activity.
    Formula:C26H22F2IN5O4S
    Colore e forma:Solid
    Peso molecolare:665.45
  • Calderasib

    CAS:
    <p>Calderasib (MK-1084) is a selective KRAS G12C inhibitor (IC50 1.2 nM) with anticancer activity, usable as monotherapy or combined with PD-1 inhibitors</p>
    Formula:C32H31ClF2N6O4
    Purezza:98.69%
    Colore e forma:Solid
    Peso molecolare:637.08